NCT06982222 2026-04-13
Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
National Cancer Institute (NCI)
Phase 1 Not yet recruiting
Clinical Trials
9 trialsNCT07495293 2026-03-27
Ultra-hypofractionated Carbon-ion Therapy for Prostate Cancer
Yonsei University
Phase 1 Not yet recruiting
NCT07493512 2026-03-25
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Amgen
Phase 1 Not yet recruiting
NCT07468396 2026-03-12
A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer
Gan & Lee Pharmaceuticals.
Phase 1 Not yet recruiting
NCT07316686 2026-01-05
Lutécio
Instituto do Cancer do Estado de São Paulo
Phase 1 Not yet recruiting
NCT07177937 2025-09-22
A Study of DXC014 in Patients With Advanced Solid Tumors.
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1 Not yet recruiting
NCT07090369 2025-07-29
LumOnate
Peter MacCallum Cancer Centre, Australia
Phase 1 Not yet recruiting
NCT06866795 2025-03-10
Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Geode Therapeutics Inc.
Phase 1 Not yet recruiting
NCT06614751 2024-09-27
A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
Danatlas Pharmaceuticals Co., Ltd
Phase 1 Not yet recruiting